News & Updates
Filter by Specialty:
Modified PDT on par with isotretinoin therapy for moderate-to-severe acne vulgaris
The modified red light 5-aminolevulinic acid photodynamic therapy (M-PDT) delivers a faster onset of improvement, similar overall efficacy, good tolerability, and comparable durability of response when compared with low-dose isotretinoin (ISO) therapy in patients with moderate-to-severe acne vulgaris, reports a study.
Modified PDT on par with isotretinoin therapy for moderate-to-severe acne vulgaris
22 Nov 2023
Melanoma diagnoses in 2020 tend to have thicker, more advanced tumours
Diagnoses of invasive cutaneous melanoma in the year 2020 are characterized by thicker, more ulcerated, and more advanced tumours, a recent study has found. Of note, a 2020 diagnosis is not associated with survival.
Melanoma diagnoses in 2020 tend to have thicker, more advanced tumours
21 Nov 2023
Dupilumab, ruxolitinib deliver benefits to atopic dermatitis patients
Treatment with dupilumab increases the levels of bone alkaline phosphatase (BALP), a marker of bone mineralization, in paediatric patients with moderate-to-severe atopic dermatitis (AD), regardless of asthma comorbidity, reports a study presented at ACAAI 2023.
Dupilumab, ruxolitinib deliver benefits to atopic dermatitis patients
17 Nov 2023
Topical diclofenac prevents HFS in capecitabine-treated cancer patients
Patients with breast or gastrointestinal (GI) cancer who are being treated with capecitabine monotherapy may benefit from using topical diclofenac gel to prevent or reduce the incidence of hand-foot syndrome (HFS), a common side effect of some chemotherapy drugs, reports a recent study presented at ESMO 2023.
